» Articles » PMID: 27534721

Influence of Elevated-CRP Level-related Polymorphisms in Non-rheumatic Caucasians on the Risk of Subclinical Atherosclerosis and Cardiovascular Disease in Rheumatoid Arthritis

Abstract

Association between elevated C-reactive protein (CRP) serum levels and subclinical atherosclerosis and cardiovascular (CV) events was described in rheumatoid arthritis (RA). CRP, HNF1A, LEPR, GCKR, NLRP3, IL1F10, PPP1R3B, ASCL1, HNF4A and SALL1 exert an influence on elevated CRP serum levels in non-rheumatic Caucasians. Consequently, we evaluated the potential role of these genes in the development of CV events and subclinical atherosclerosis in RA patients. Three tag CRP polymorphisms and HNF1A, LEPR, GCKR, NLRP3, IL1F10, PPP1R3B, ASCL1, HNF4A and SALL1 were genotyped in 2,313 Spanish patients by TaqMan. Subclinical atherosclerosis was determined in 1,298 of them by carotid ultrasonography (by assessment of carotid intima-media thickness-cIMT-and presence/absence of carotid plaques). CRP serum levels at diagnosis and at the time of carotid ultrasonography were measured in 1,662 and 1,193 patients, respectively, by immunoturbidimetry. Interestingly, a relationship between CRP and CRP serum levels at diagnosis and at the time of the carotid ultrasonography was disclosed. However, no statistically significant differences were found when CRP, HNF1A, LEPR, GCKR, NLRP3, IL1F10, PPP1R3B, ASCL1, HNF4A and SALL1 were evaluated according to the presence/absence of CV events, carotid plaques and cIMT after adjustment. Our results do not confirm an association between these genes and CV disease in RA.

Citing Articles

Diagnostic value of C-reactive protein/ albumin ratio and TMTC1 in intracranial atherosclerotic stenosis in patients with acute cerebral infarction.

Mo J, Liu L, Li Z, Hu Z, Tan Y, Long G Sci Rep. 2025; 15(1):8653.

PMID: 40082626 PMC: 11906579. DOI: 10.1038/s41598-025-92714-1.


A review on the treatment of hyperlipidemia with Erchen Decoction.

Tian X, Liu P, Wang R, Hou Y, Zhou Y, Wang C Front Pharmacol. 2024; 15:1445950.

PMID: 39605912 PMC: 11598526. DOI: 10.3389/fphar.2024.1445950.


TM6SF2-rs58542926 Genetic Variant Modifies the Protective Effect of a "Prudent" Dietary Pattern on Serum Triglyceride Levels.

Kalafati I, Dimitriou M, Revenas K, Kokkinos A, Deloukas P, Dedoussis G Nutrients. 2023; 15(5).

PMID: 36904112 PMC: 10005630. DOI: 10.3390/nu15051112.


Circulating levels of DDIT4 and mTOR, and contributions of BMI, inflammation and insulin sensitivity in hyperlipidemia.

Pan X, Zhang Z, Liu C, Zhao M, Wang X, Zhai J Exp Ther Med. 2022; 24(5):666.

PMID: 36168416 PMC: 9475340. DOI: 10.3892/etm.2022.11602.


Osteoprotegerin and MTHFR gene variations in rheumatoid arthritis: association with disease susceptibility and markers of subclinical atherosclerosis.

Arida A, Nezos A, Papadaki I, Sfikakis P, Mavragani C Sci Rep. 2022; 12(1):9534.

PMID: 35680906 PMC: 9184606. DOI: 10.1038/s41598-022-13265-3.


References
1.
Corrales A, Gonzalez-Juanatey C, Peiro M, Blanco R, Llorca J, Gonzalez-Gay M . Carotid ultrasound is useful for the cardiovascular risk stratification of patients with rheumatoid arthritis: results of a population-based study. Ann Rheum Dis. 2013; 73(4):722-7. DOI: 10.1136/annrheumdis-2012-203101. View

2.
Dessein P, Norton G, Woodiwiss A, Joffe B, Wolfe F . Influence of nonclassical cardiovascular risk factors on the accuracy of predicting subclinical atherosclerosis in rheumatoid arthritis. J Rheumatol. 2007; 34(5):943-51. View

3.
Gonzalez-Juanatey C, Llorca J, Martin J, Gonzalez-Gay M . Carotid intima-media thickness predicts the development of cardiovascular events in patients with rheumatoid arthritis. Semin Arthritis Rheum. 2008; 38(5):366-71. DOI: 10.1016/j.semarthrit.2008.01.012. View

4.
Lopez-Mejias R, Genre F, Remuzgo-Martinez S, Robledo G, Llorca J, Corrales A . Vitamin D receptor GATG haplotype association with atherosclerotic disease in patients with rheumatoid arthritis. Atherosclerosis. 2016; 245:139-42. DOI: 10.1016/j.atherosclerosis.2015.12.011. View

5.
Tedgui A, Mallat Z . Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol Rev. 2006; 86(2):515-81. DOI: 10.1152/physrev.00024.2005. View